OLMA
NASDAQ
$11.35
Olema Pharmaceuticals Inc (OLMA)
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. The company is headquartered in San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $40.70 (+258.59%)
Market Cap
$1.03B
FCF 5Y CAGR
+38.41%
Free Cash Flow Yield
-14.41%
Beta (5Y)
0.72
Price Chart
Valuation
Market Cap$1.03B
P/B2.15
Profitability
EBITDA-$201M
EPS-$2.43
Financial Health
Free Cash Flow Yield-14.41%
Growth & Risk
FCF 5Y CAGR+38.41%
Beta (5Y)0.72
Sharpe Ratio1.09